Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update. uri icon

Overview

abstract

  • ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.

publication date

  • August 18, 2021

Research

keywords

  • Adenocarcinoma
  • Esophageal Neoplasms
  • Esophageal Squamous Cell Carcinoma
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Nivolumab

Identity

Scopus Document Identifier

  • 85117740067

Digital Object Identifier (DOI)

  • 10.1200/JCO.21.01831

PubMed ID

  • 34406872

Additional Document Info

volume

  • 39

issue

  • 28